Global Influenza diagnostics Market to reach USD 3.6 billion by 2025.

Global Influenza diagnostics Market valued approximately USD 1.91 billion in 2016 is anticipated to grow with a healthy growth rate of more than 6.4% over the forecast period 2017-2025. Influenza, which is commonly called the flu is an infectious disease of the upper respiratory system caused by the influenza virus. The seasonal influenza virus has three types, namely influenza B, influenza A, and influenza C that are differentiated on the basis of two major surface proteins namely, hemagglutinin (HA) and neuraminidase (NA). Various serotypes are seen based on differences in these surface proteins that determine the antibody response to the viruses.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Test type:
 
§ RIDT
§ RT-PCR
§ Cell culture

By End Use:

§ Hospitals
§ Laboratories
§ POCT


By Regions:
§ North America
o U.S.
o Canada
§ Europe
o UK
o Germany
§ Asia Pacific
o China
o India
o Japan
§ Latin America
o Brazil
o Mexico
§ Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market 3AM Healthcare, Alere, meridian bioscience, Inc., Quidel corporation, Roche diagnostics corporation, SA Scientific, Thermo fisher scientific Inc. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Influenza diagnostics Market in Market Study:

§ Key Consulting Companies & Advisors
§ Large, medium-sized, and small enterprises
§ Venture capitalists
§ Value-Added Resellers (VARs)
§ Third-party knowledge providers
§ Investment bankers
§ Investors